Log in | Register

Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis

Nor’azim Mohd Yunos| Rinaldo Bellomo| Neil Glassford| Harvey Sutcliffe| Que Lam| Michael Bailey
Original
Volume 41, Issue 2 / February , 2015

Pages 257 - 264

Abstract

Purpose

In a previous study, restricting intravenous chloride administration in ICU patients decreased the incidence of acute kidney injury (AKI). To test the robustness of this finding, we extended our observation period to 12 months.

Methods

The study extension included a 1-year control period (18 August 2007 to 17 August 2008) and a 1-year intervention period (18 February 2009 to 17 February 2010). During the extended control period, patients received standard intravenous fluids. During the extended intervention period, we continued to restrict all chloride-rich fluids. We used the Kidney Disease: Improving Global Outcomes (KDIGO) staging to define AKI.

Results

We studied 1,476 control and 1,518 intervention patients. Stages 2 and 3 of KDIGO defined AKI decreased from 302 (20.5 %; 95 % CI, 18.5–22.6 %) to 238 (15.7 %; 95 % CI, 13.9–17.6 %) (P < 0.001) and the use of RRT from 144 (9.8 %; 95 % CI, 8.3–11.4 %) to 103 (6.8 %; 95 % CI, 5.6–8.2 %) (P = 0.003). After adjustment for relevant covariates, liberal chloride therapy remained associated with a greater risk of KDIGO stages 2 and 3 [hazard ratio 1.32 (95 % CI 1.11–1.58); P = 0.002] and use of RRT [hazard ratio 1.44 (95 % CI 1.10–1.88); P = 0.006]. However, on sensitivity assessment of each 6-month period, KDIGO stages 2 and 3 increased in the new extended intervention period compared with the original intervention period.

Conclusions

On extended assessment, the overall impact of restricting chloride-rich fluids on AKI remained. However, sensitivity analysis suggested that other unidentified confounders may have also contributed to fluctuations in the incidence of AKI.

Keywords

References

  1. Myburgh JA, Mythen MG (2013) Resuscitation fluids. N Engl J Med 369:1243–1251
    • View reference on PubMed
    • View reference on publisher's website
  2. Chowdhury AH, Cox EF, Francis ST, Lobo DN (2012) A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9 % saline and Plasma-Lyte 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 256:18–24
    • View reference on PubMed
    • View reference on publisher's website
  3. Chowdhury AH, Cox EF, Francis ST, Lobo DN (2014) A randomized, controlled, double-blind crossover study on the effects of 1-L infusions of 6 % hydroxyethyl starch suspended in 0.9 % saline (Voluven) and a balanced solution (Plasma Volume Redibag) on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers. Ann Surg 259:881–887
    • View reference on PubMed
    • View reference on publisher's website
  4. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M (2012) Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308:1566–1572
    • View reference on PubMed
    • View reference on publisher's website
  5. Waikar SS, Winkelmayer WC (2012) Saving the kidneys by sparing intravenous chloride? JAMA 308:1583–1585
    • View reference on PubMed
    • View reference on publisher's website
  6. Yunos NM, Kim IB, Bellomo R, Bailey M, Ho L, Story D, Gutteridge GA, Hart GK (2011) The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med 39:2419–2424
    • View reference on PubMed
    • View reference on publisher's website
  7. RENAL Study Investigators (2008) Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey. Crit Care Resusc 10:225–230
  8. Bellomo R, Cass A, Cole L, Cass A, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S, RENAL Replacement Therapy Study Investigators (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638
    • View reference on PubMed
    • View reference on publisher's website
  9. The KDIGO Acute Kidney Injury Work Group (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2(Suppl):1–138
  10. Závada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G, Bellomo R, Kellum JA, AKI6 investigators (2010) A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transpl 25:3911–3918
    • View reference on publisher's website
  11. Gray R (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141–1154
    • View reference on publisher's website
  12. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA (2012) Major complications, mortality, and resource utilization after open abdominal surgery: 0.9 % saline compared to Plasma-Lyte. Ann Surg 255:821–829
    • View reference on PubMed
    • View reference on publisher's website
  13. McCluskey SA, Karkouti K, Wijeysundera D, Minkovich L, Tait G, Beattie WS (2013) Hyperchloremia after non-cardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg 117:412–421
    • View reference on PubMed
    • View reference on publisher's website
  14. Ke L, Calzavacca P, Bailey M, May CN, Li WQ, Bertolin J, Bellomo R (2014) Systemic and hemodynamic effects of fluid bolus therapy: sodium chloride versus sodium octanoate. Crit Care Resusc 16(1):29–33
    • View reference on PubMed
  15. Bihari S, Peake SL, Seppelt I, Wiliams P, Wilkins B, Bersten A (2013) Sodium administration in critically ill patients in Australia and New Zealand: a multicentre point prevalence study. Crit Care Resusc 15:294–300
    • View reference on PubMed
  16. Bihari S, Festa M, Peake SL, Seppelt I, Wiliams P, Wilkins B, Bersten A (2014) Sodium administration in critically ill paediatric patients in Australia and New Zealand: a multicentre point prevalence study. Crit Care Resusc 16:112–118
    • View reference on PubMed
  17. Gattas D, Saxena MK (2013) Is maintenance fluid therapy in need of maintenance? Crit Care Resusc 15:255–256
    • View reference on PubMed
  18. Raghunathan K, Shaw A, Nathanson B, Stürmer T, Brookhart A, Stefan MS, Setoguchi S, Beadles C, Lindenauer PK (2014) Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 42:1585–1591
    • View reference on PubMed
    • View reference on publisher's website
  19. Shaw AD, Raghunathan A, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR (2014) Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med 40:1897–1905
  20. Sharek PJ, Parast LM, Leong K, Coombs J, Earnest K, Sullivan J, Frankel LR, Roth SJ (2007) Effect of a rapid response team on hospital-wide mortality and code rates outside the ICU in a children’s hospital. JAMA 298:2267–2274
    • View reference on PubMed
    • View reference on publisher's website
  21. Chan PS, Khalid A, Longmore LS, Berg RA, Kosiborod M, Spertus JA (2008) Hospital-wide code rates and mortality before and after implementation of a rapid response team. JAMA 300:2506–2513
    • View reference on PubMed
    • View reference on publisher's website
  22. Cruz DN, Ricci Z, Ronco C (2009) Clinical review: RIFLE and AKIN—time for reappraisal. Crit Care 13(3):211
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement